Sorry, you need to enable JavaScript to visit this website.

XYNTHA® Solofuse Lyophilized Powder for Solution in Prefilled Dual-chamber Syringe (antihemophilic factor [Recombinant]) Indications and Usage

1 INDICATIONS AND USAGE

XYNTHA, Antihemophilic Factor (Recombinant), is indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for:

  • On-demand treatment and control of bleeding episodes
  • Perioperative management
  • Routine prophylaxis to reduce the frequency of bleeding episodes

XYNTHA does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No